The Impact of Employee Wellness Programs

September 7, 2021 updated by: Zirui Song, Harvard School of Public Health (HSPH)
There is great public and private interest in the use of workplace wellness programs to reduce health care spending, improve health outcomes, and enhance productivity for employees. However, there is little rigorous evidence on the effects of wellness programs. This study partners with a large multi-state U.S. employer (BJ's Wholesale Club) and an experienced wellness vendor (Wellness Workdays) to evaluate a multi-prong workplace wellness program, including components such as nutrition counseling, fitness challenges, and stress management workshops. The wellness program will be delivered by a team of experts including Registered Dieticians, and will include financial rewards for participation. The program will be available to employees in initially 20 of BJ's 200 worksites, and later expanded to 25 worksites. These worksites have been randomly selected, allowing a randomized controlled trial evaluation of the effects of the wellness program. Data will be collected on a wide array of outcomes from multiple sources, including on-site biometric screenings and surveys, employment records, and health insurance claims for employees at both treatment and control worksites.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

48664

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Employed in one of BJ's clubs during the period of the intervention

Exclusion Criteria:

  • Not employed in one of BJ's clubs during the period of the intervention

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Treatment
Employees at treatment worksites will be given access to workplace wellness programming. Participation by employees will be voluntary, but all employees at treatment sites will be considered as part of the treatment group. Employees will also be invited to complete on-site biometric assessments and questionnaires. Data from secondary data sources (including employment records and health insurance claims) will be collected for employees at all BJ's worksites.
Multi-prong workplace wellness program, with components such as nutrition counseling, fitness challenges, and stress management workshops, including supports and incentives.
No Intervention: Primary Control
Employees at primary control worksites will be invited to complete on-site biometric assessments and questionnaires, but will not have access to the workplace wellness programming. Data from secondary data sources (including employment records and health insurance claims) will be collected for employees at all BJ's worksites.
No Intervention: Secondary Control
Employees at secondary control worksites will not participate in in-person screenings or questionnaires, and will not have access to workplace wellness programming. Data from secondary data sources (including employment records and health insurance claims) will be collected for employees at all BJ's worksites.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical activity
Time Frame: Primary data collected at 18 months and 30 months after initiation of intervention
Regular exercise, number of hours sitting per day, and actively managing weight, as indicated in responses to survey questions
Primary data collected at 18 months and 30 months after initiation of intervention
Obesity
Time Frame: Primary data collected at 18 months and 30 months after initiation of intervention
Body Mass Index>=30, calculated from measured height and weight
Primary data collected at 18 months and 30 months after initiation of intervention
Absenteeism
Time Frame: Administrative records from 3 years spanning intervention
Number of sick or personal days as a share of total days employed, from employment records
Administrative records from 3 years spanning intervention
Health care spending
Time Frame: Administrative records from 3 years spanning intervention
Dollars spent on health care for employees covered by employer-sponsored insurance, from claims records
Administrative records from 3 years spanning intervention

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood pressure
Time Frame: Primary data collected at 18 months and 30 months after initiation of intervention
Systolic blood pressure, measured
Primary data collected at 18 months and 30 months after initiation of intervention
Depression
Time Frame: Primary data collected at 18 months and 30 months after initiation of intervention
Unmanaged depression, as indicated in responses to survey questions
Primary data collected at 18 months and 30 months after initiation of intervention
Tenure
Time Frame: Administrative records from 3 years spanning intervention
Duration of employment in days, from employment records
Administrative records from 3 years spanning intervention
Job performance
Time Frame: Administrative records from 3 years spanning intervention
Numerical performance rating from annual review, from employment records
Administrative records from 3 years spanning intervention
Health care spending (i.e. dollars spent)
Time Frame: Administrative records from 3 years spanning intervention
Dollars spent on health care and prescription drugs for employees covered by employer-sponsored insurance, decomposed into spending on inpatient, outpatient, emergency department, and prescription drugs, from claims records
Administrative records from 3 years spanning intervention
Health care utilization (i.e. number of doctor visits, hospitalizations, or medications)
Time Frame: Administrative records from 3 years spanning intervention
Health care encounters and prescription drugs for employees covered by employer-sponsored insurance, decomposed into inpatient, outpatient, emergency department, and prescription drugs, from claims records
Administrative records from 3 years spanning intervention
Nutrition management
Time Frame: Primary data collected at 18 months and 30 months after initiation of intervention
Affirmative engagement in active efforts to improve nutrition, as indicated in responses to survey questions
Primary data collected at 18 months and 30 months after initiation of intervention
Stress management
Time Frame: Primary data collected at 18 months and 30 months after initiation of intervention
Unmanaged stress and stress at work, as indicated in responses to survey questions
Primary data collected at 18 months and 30 months after initiation of intervention
Screenings and exams
Time Frame: Primary data collected at 18 months and 30 months after initiation of intervention
Percent of recommended tests received, as indicated in responses to survey questions
Primary data collected at 18 months and 30 months after initiation of intervention
Tobacco use
Time Frame: Primary data collected at 18 months and 30 months after initiation of intervention
Smoking, as indicated in responses to survey questions
Primary data collected at 18 months and 30 months after initiation of intervention
Health and wellbeing
Time Frame: Primary data collected at 18 months and 30 months after initiation of intervention
Short form 8 (SF-8) physical and mental summary scores, as indicated in responses to survey questions. Each question of the SF-8 uses a 5- or 6-point Likert scale. Its standardized scoring system combines responses into a score that can be interpreted as a continuous variable (analogous to a 0-100 scale), with higher scores denoting better self-reported health.
Primary data collected at 18 months and 30 months after initiation of intervention
Blood glucose
Time Frame: Primary data collected at 18 months and 30 months after initiation of intervention
Blood glucose, measured
Primary data collected at 18 months and 30 months after initiation of intervention
Cholesterol
Time Frame: Primary data collected at 18 months and 30 months after initiation of intervention
Total cholesterol and high-density lipoprotein (HDL), measured
Primary data collected at 18 months and 30 months after initiation of intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Zirui Song, MD, PhD, Harvard Medical School (HMS and HSDM)

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2015

Primary Completion (Actual)

October 1, 2018

Study Completion (Actual)

June 1, 2021

Study Registration Dates

First Submitted

May 23, 2017

First Submitted That Met QC Criteria

May 24, 2017

First Posted (Actual)

May 30, 2017

Study Record Updates

Last Update Posted (Actual)

September 9, 2021

Last Update Submitted That Met QC Criteria

September 7, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • Wellness 14-3141
  • R01AG050329 (U.S. NIH Grant/Contract)
  • P30AG012810 (U.S. NIH Grant/Contract)
  • 72611 (Other Grant/Funding Number: Robert Wood Johnson Foundation)
  • AEARCTR-0000586 (Registry Identifier: American Economic Association Trial Registry)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Health Behavior

Clinical Trials on Workplace wellness program

3
Subscribe